| Regulatory
Matters |
| • |
Aspirin
with either phytosterols or calcium |
| • |
Fentanyl
transdermal delivery system |
| • |
Herbal
medicines |
| • |
Natalizumab |
| • |
OTC
cough and cold medicines |
| • |
Rimonabant |
| • |
Topical
papain-containing products |
| • |
Xanthoanthrafil-
containing sexual dysfunction products |
|
Safety of Medicines |
| • |
Antipsychotics |
| • |
Codeine
products |
| • |
Colchicine
|
| • |
Drug-induced
hyponatraemia |
| • |
Drugs
affecting renin-angiotensin-aldosterone system |
| • |
Efalizumab |
| • |
Epoetin-alfa |
| • |
Erlotinib |
| • |
Fentanyl
patches |
| • |
Fluoroquinolone |
| • |
Icodextrin |
| • |
Lenalidomide |
| • |
Levothyroxine |
| • |
Mefloquine |
| • |
Paracetamol |
| • |
Phenytoin |
| • |
Chromic-phosphate-P-32 |
| • |
Rituximab |
| • |
Venlafaxine |
| Feature |
| • |
Drotrecogin
alfa - Thrombosis |
